Downregulation of de Novo Fatty Acid Synthesis in Subcutaneous Adipose Tissue of Moderately Obese Women
暂无分享,去创建一个
C. Richart | D. Del Castillo | G. Aragonès | R. Jorba | C. Aguilar | T. Auguet | Cristóbal Richart | Esther Guiu-Jurado | Teresa Auguet | Alba Berlanga | Gemma Aragonès | Carmen Aguilar | Fàtima Sabench | Sandra Armengol | José Antonio Porras | Andreu Martí | Rosa Jorba | Mercè Hernández | Daniel del Castillo | Sandra Armengol | J. Porras | F. Sabench | Mercé Hernández | A. Berlanga | Andreu Martí | Esther Guiu-Jurado | Gemma Aragonès
[1] H. Vidal,et al. Effect of carbohydrate overfeeding on whole body macronutrient metabolism and expression of lipogenic enzymes in adipose tissue of lean and overweight humans , 2004, International Journal of Obesity.
[2] R. Seeley,et al. Subcutaneous adipose tissue transplantation in diet-induced obese mice attenuates metabolic dysregulation while removal exacerbates it , 2013, Physiological reports.
[3] Tomoya Sakamoto,et al. Activation of peroxisome proliferator-activated receptor-α enhances fatty acid oxidation in human adipocytes. , 2011, Biochemical and biophysical research communications.
[4] M. Moreno-Aliaga,et al. α‐lipoic acid reduces fatty acid esterification and lipogenesis in adipocytes from overweight/obese subjects , 2014, Obesity.
[5] C. Roberts,et al. Sex-Specific Differences in Lipid and Glucose Metabolism , 2014, Front. Endocrinol..
[6] A. Vidal-Puig,et al. It's Not How Fat You Are, It's What You Do with It That Counts , 2008, PLoS biology.
[7] M. Blüher,et al. Adipocyte dysfunction, inflammation and metabolic syndrome , 2014, Reviews in Endocrine and Metabolic Disorders.
[8] M. Fasshauer,et al. Insulin-sensitive obesity. , 2010, American journal of physiology. Endocrinology and metabolism.
[9] N. Lundbom,et al. Comparison of the Relative Contributions of Intra‐Abdominal and Liver Fat to Components of the Metabolic Syndrome , 2011, Obesity.
[10] M. Haluzík,et al. The endocrine profile of subcutaneous and visceral adipose tissue of obese patients , 2008, Molecular and Cellular Endocrinology.
[11] M. Jensen,et al. Fat Depots, Free Fatty Acids, and Dyslipidemia , 2013, Nutrients.
[12] K. Cianflone,et al. Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects , 2010, BMC Medical Genomics.
[13] P. Arner,et al. Changes in Adipose Tissue Gene Expression with Energy-restricted Diets in Obese Women , 2022 .
[14] M. Hellerstein,et al. The effect of dietary carbohydrate on genes for fatty acid synthase and inflammatory cytokines in adipose tissues from lean and obese subjects. , 2008, The Journal of nutritional biochemistry.
[15] B. Lecka-Czernik,et al. The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment Published, JLR Papers in Press, August 7, 2006. , 2006, Journal of Lipid Research.
[16] F. Tinahones,et al. Obesity and Insulin Resistance-Related Changes in the Expression of Lipogenic and Lipolytic Genes in Morbidly Obese Subjects , 2010, Obesity surgery.
[17] C. Richart,et al. Downregulation of lipogenesis and fatty acid oxidation in the subcutaneous adipose tissue of morbidly obese women , 2014, Obesity.
[18] J. Nielsen,et al. Defining the human adipose tissue proteome to reveal metabolic alterations in obesity. , 2014, Journal of proteome research.
[19] G. Reaven. Importance of Identifying the Overweight Patient Who Will Benefit the Most by Losing Weight , 2003, Annals of Internal Medicine.
[20] Andrew R Coggan,et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. , 2004, The New England journal of medicine.
[21] F. Karpe,et al. Gluteofemoral body fat as a determinant of metabolic health , 2010, International Journal of Obesity.
[22] A. Greenberg,et al. Sex differences in human adipose tissues – the biology of pear shape , 2012, Biology of Sex Differences.
[23] Haowei Song,et al. Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARγ activation to decrease diet-induced obesity. , 2012, Cell metabolism.
[24] BOULIN,et al. Classification and Diagnosis of Diabetes. , 2022, Primary care.
[25] W. Shen,et al. Gender differences in insulin resistance, body composition, and energy balance. , 2009, Gender medicine.
[26] S. O’Rahilly,et al. Lipodystrophy: metabolic insights from a rare disorder. , 2010, The Journal of endocrinology.
[27] C. Richart,et al. Retinol binding protein‐4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women , 2012, Obesity.
[28] M. Visser,et al. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. , 2004, Diabetes care.
[29] R. V. Van Pelt,et al. Contributions of total and regional fat mass to risk for cardiovascular disease in older women. , 2002, American journal of physiology. Endocrinology and metabolism.
[30] M. Blüher. Adipose tissue dysfunction contributes to obesity related metabolic diseases. , 2013, Best practice & research. Clinical endocrinology & metabolism.
[31] M. Lean,et al. Pathophysiology of obesity , 2000, Proceedings of the Nutrition Society.
[32] M. Visser,et al. Larger thigh and hip circumferences are associated with better glucose tolerance: the Hoorn study. , 2003, Obesity research.
[33] R. Evans,et al. Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity , 2003, Cell.
[34] H. Kalbacher,et al. De novo lipogenesis in health and disease. , 2014, Metabolism: Clinical and Experimental.
[35] S. Heymsfield,et al. Femoral-gluteal subcutaneous and intermuscular adipose tissues have independent and opposing relationships with CVD risk. , 2008, Journal of applied physiology.
[36] B. Walker,et al. Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome. , 2008, The Journal of endocrinology.
[37] J. Moreno-Navarrete,et al. The Gene Expression of the Main Lipogenic Enzymes is Downregulated in Visceral Adipose Tissue of Obese Subjects , 2010, Obesity.
[38] V. Large,et al. Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue Published, JLR Papers in Press, August 1, 2003. DOI 10.1194/jlr.M300235-JLR200 , 2003, Journal of Lipid Research.
[39] Jimmy D Bell,et al. Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. , 2003, Diabetes.
[40] F. Lönnqvist,et al. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding , 2002, International Journal of Obesity.
[41] J. Després,et al. Abdominal obesity and metabolic syndrome , 2006, Nature.
[42] M. Beylot,et al. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. , 2002, American journal of physiology. Endocrinology and metabolism.
[43] Fritz Schick,et al. Identification and characterization of metabolically benign obesity in humans. , 2008, Archives of internal medicine.
[44] G. Shulman,et al. Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice* , 2000, The Journal of Biological Chemistry.